T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $164B
1-Year Est. Return 17.05%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Quarter Est. Return
1 Year Est. Return
+17.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$164B
AUM Growth
+$5.22B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
939
New
Increased
Reduced
Closed

Top Buys

1 +$3B
2 +$1.34B
3 +$1.26B
4
NVDA icon
NVIDIA
NVDA
+$1.09B
5
AVGO icon
Broadcom
AVGO
+$1.05B

Top Sells

1 +$1.18B
2 +$1.13B
3 +$1.06B
4
MSFT icon
Microsoft
MSFT
+$1.05B
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$961M

Sector Composition

1 Technology 27.68%
2 Healthcare 19.29%
3 Consumer Discretionary 13.58%
4 Financials 10.5%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
651
Intuitive Surgical
ISRG
$201B
$490K ﹤0.01%
1,095
+265
ELV icon
652
Elevance Health
ELV
$74.7B
$488K ﹤0.01%
1,508
-2,080
ASML icon
653
ASML
ASML
$433B
$445K ﹤0.01%
459
-289,963
FISV
654
Fiserv Inc
FISV
$35.3B
$440K ﹤0.01%
3,411
-849
ACN icon
655
Accenture
ACN
$167B
$287K ﹤0.01%
1,160
-204
CVS icon
656
CVS Health
CVS
$94.4B
$258K ﹤0.01%
3,410
+842
REGN icon
657
Regeneron Pharmaceuticals
REGN
$76.2B
$245K ﹤0.01%
435
+147
EW icon
658
Edwards Lifesciences
EW
$49.3B
$195K ﹤0.01%
2,506
+416
DXCM icon
659
DexCom
DXCM
$25.2B
$145K ﹤0.01%
2,149
+1,906
SNY icon
660
Sanofi
SNY
$120B
$118K ﹤0.01%
2,489
+782
AZN icon
661
AstraZeneca
AZN
$280B
$88K ﹤0.01%
1,141
+228
APGE icon
662
Apogee Therapeutics
APGE
$5.21B
$58K ﹤0.01%
1,441
+977
QURE icon
663
uniQure
QURE
$1.42B
$58K ﹤0.01%
+977
LLYVA icon
664
Liberty Live Group Series A
LLYVA
$7.34B
$48K ﹤0.01%
+506
ROIV icon
665
Roivant Sciences
ROIV
$14.7B
$40K ﹤0.01%
+2,629
ENOV icon
666
Enovis
ENOV
$1.61B
$37K ﹤0.01%
1,211
+9
OM icon
667
Outset Medical
OM
$79.5M
$34K ﹤0.01%
2,399
-1,621,137
ETNB
668
DELISTED
89bio
ETNB
$31K ﹤0.01%
2,047
+1,073
TEVA icon
669
Teva Pharmaceuticals
TEVA
$32.3B
$30K ﹤0.01%
1,468
-831
IOVA icon
670
Iovance Biotherapeutics
IOVA
$885M
$28K ﹤0.01%
12,638
-169,798
PODD icon
671
Insulet
PODD
$22.1B
$28K ﹤0.01%
90
+11
ICUI icon
672
ICU Medical
ICUI
$3.54B
$26K ﹤0.01%
215
-128
WBS icon
673
Webster Financial
WBS
$10.1B
$26K ﹤0.01%
428
-892,660
ADC icon
674
Agree Realty
ADC
$8.57B
$24K ﹤0.01%
+335
MRNA icon
675
Moderna
MRNA
$10B
$24K ﹤0.01%
893
+212